Literature DB >> 29853461

Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.

Ibrahim Aldoss1, Joo Y Song1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29853461     DOI: 10.1182/blood-2018-02-834911

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies.

Authors:  Federico Lussana; Giuseppe Gritti; Alessandro Rambaldi
Journal:  J Clin Oncol       Date:  2021-01-12       Impact factor: 44.544

2.  Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review.

Authors:  Reina Takeda; Kazuaki Yokoyama; Tomofusa Fukuyama; Toyotaka Kawamata; Mika Ito; Nozomi Yusa; Rika Kasajima; Eigo Shimizu; Nobuhiro Ohno; Kaoru Uchimaru; Rui Yamaguchi; Seiya Imoto; Satoru Miyano; Arinobu Tojo
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

3.  An Unusual Presentation of Extramedullary Relapse Following Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Authors:  Sanae Daghri; Mounia Bendari; Nadia Belmoufid; Anass Yahyaoui; Maryame Ahnach
Journal:  Cureus       Date:  2022-03-17

4.  Circular RNA and mRNA profiling reveal competing endogenous RNA networks during avian leukosis virus, subgroup J-induced tumorigenesis in chickens.

Authors:  Lingling Qiu; Guobin Chang; Yulin Bi; Xiangping Liu; Guohong Chen
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 5.  Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia.

Authors:  Seth E Karol; Ching-Hon Pui
Journal:  Ther Adv Hematol       Date:  2020-06-02

6.  LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.

Authors:  Gabriel Gracia-Maldonado; Jason Clark; Matthew Burwinkel; Brenay Greenslade; Mark Wunderlich; Nathan Salomonis; Dario Leone; Evelina Gatti; Philippe Pierre; Ashish R Kumar; Lynn H Lee
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

Review 7.  Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.

Authors:  Wenjuan Liao; M Eric Kohler; Terry Fry; Patricia Ernst
Journal:  Exp Hematol       Date:  2021-07-21       Impact factor: 3.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.